Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.

Adduct Analys offer a unique method for therapeutic drug monitoring that allows us to measure the active blood levels of substances.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Stemirna Therapeutics Co., Ltd. is a company headquartered in Shanghai, China. The firm develops precise cancer immunotherapy technology platform. It was founded in 2016 by Hai Fa Shen, Hang Wen Li and Ding Guo Tang. Hang Wen Li has been the CEO since the company founding.\nThe company says this about itself: StemiRNA therapeutics is a clinical stage mRNA biopharmaceutical company located in Shanghai, Beijing and Boston. With a proprietary LPP delivery system, the company has developed a broad portfolio of novel mRNA based vaccines and therapeutics with focuses on infectious disease and oncology. The company's lead product candidate, mRNA COVID-19 vaccine, is in clinical stage in multiple countries. StemiRNA also developed in-house CMC and manufacturing capabilities and advanced capacity in Shanghai.

Provides pharmaceutical services

Part of PerkinElmer, Inc. (United States), Perkin Elmer Ltd. is a South Korean company. The firm manufactures pharmaceutical products.

Applera Corp. manufactures medical instruments

Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The firm specializes in tumor immunotherapy and immune cell therapy. Its business scope includes research and development of biotechnology, technology transfer, and technical advisory services; and wholesale and retail of biological drugs. The company was founded by Peng Fei Zhou, Qian Yuan, and Hong Feng Zhou on July 8, 2010 and is headquartered in Wuhan, China.

Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA.

Zhejiang Funuo Pharmaceutical Co., Ltd., established on 2002-12-19, Business scope includes licensed projects:pharmaceutical production;Production of medical masks;Pharmaceutical commissioned production;Production of protective equipment for medical personnel(Class II medical device);Disinfectant production(Free of Hazardous Chemicals);Production of hygiene products and single-use medical products;Production of Class II Medical Devices;Production of Class III Medical Devices;Cosmetic production;Health food production;Drug import and export;Drug Wholesale;Drug retail;Drug internet information service;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of protective equipment for medical personnel(Ι class medical device);Production of Class I Medical Devices;Health Consulting Services(Does not include medical services);Cosmetics Wholesale;Cosmetics Retail;Maternal and baby products manufacturing;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Fermentation process optimization technology research and development;Research and development of bio-based materials technology;R&D of industrial enzyme preparations;Biochemical product technology research and development;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Medical Research and Experimental Development;daily mask(non-medical)Production;Manufacturing of daily chemical products;Non-residential real estate leases;Healthy food(prepackaged)Sales;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and selective oral molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera. The company was founded by John Hood, Catriona Jamieson and Raghu Saripalli in 2016 and is headquartered in San Diego, CA.

Ningbo Scientz Biotechnology Co., Ltd. engages in the provision of biological sample processing equipment. Its products include biological sample pre-processing equipment, molecular biology equipment, laboratory clean equipment, freeze-drying equipment, and industrial anti-scaling equipment. The company was founded by Fang Zhou and Chang Jin Xiao in 1989 and is headquartered in Ningbo, China.

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.